CORRELATION BETWEEN BODY MASS INDEX (BMI), BLOOD PRESSURE, GLUICOSE LEVELS AND AGES
DOI:
https://doi.org/10.31154/isc12.v12i1.7.1-8Keywords:
age, BMIAbstract
Obesity is a growing global public health problem. Patients with obesity are at high risk for a variety of comorbid conditions, including cardiovascular disease, gastrointestinal disorders, type 2 diabetes, joint and muscle disorders, respiratory problems, and psychological problems, which can significantly impact life and increase the risk of death. Even modest weight loss can enable patients to reduce their risk of cardiovascular disease, diabetes, obstructive sleep apnea and hypertension among many other comorbidities. Purposive sampling is used in this study's descriptive correlational approach. This study aimed to determine the correlation between Body Mass Index (BMI), Blood Pressure, Blood Glucose s and ages in Wiyono Village Lampung, were chosen as the research sites for this study. In all, 40 adult residents participated in this study. Both one- and two-variable analyses were carried out. Measurements of BMI, blood pressure and blood samples to determine blood glucose levels were part of the data gathering process. Following the results, health professionals provided counselling on a healthy lifestyle to each responder based on the findings of their assessment. The data show that there is a significant correlation between age and blood pressure, with a significant value of 0.001 < 0.05 and a moderate positive correlation (r = -0.513), which means that as age increases, blood pressure tends to increase. Techniques for implementing healthy lifestyle education, sustainable weight management, and routine weight maintenance are essential to prevent the impact of diseases caused by obesity, increased blood pressure and blood sugar levels.
References
Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001. JAMA 2003;289:76-9. 10.1001/jama.289.1.76
Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004;23:6365-78. 10.1038/sj.onc.1207751
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-72. 10.1016/S0140-6736(13)60687-X
Garrison RJ, Kannel WB, Stokes J, 3rd, et al. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:235-51. 10.1016/0091-7435(87)90087-9
Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6. 10.1016/S0140-6736(01)06710-1
Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009;302:401-11. 10.1001/jama.2009.1060
Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001;134:1-11. 10.7326/0003-4819-134-1-200101020-00007
Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42:878-84. 10.1161/01.HYP.0000094221.86888.AE
Aucott L, Poobalan A, Smith WC, et al. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 2005;45:1035-41. 10.1161/01.HYP.0000165680.59733.d4
Faulkner JL, Belin de Chantemele EJ. Sex Differences in Mechanisms of Hypertension Associated With Obesity. Hypertension 2018;71:15-21. 10.1161/HYPERTENSIONAHA.117.09980
Adnan, M., Mulyati, T., & Isworo, J. T. (2013). Hubungan Indeks Massa Tubuh (IMT) Dengan Kadar Gula Darah Penderita Diabetes Mellitus (DM) Tipe 2 Rawat Jalan Di RS Tugurejo Semarang. Jurnal Gizi, 2(1)
Gastaldelli, A., Abdul Ghani, M., & DeFronzo, R. A. (2021). Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance. Diabetes, 70(2), 377–385.
Chandrasekaran, P., & Weiskirchen, R. (2024). The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. International Journal of Molecular Sciences, 25(3), 1882.

